Trending:

Chris Lo

All articles by Chris Lo

  1. Congo Ebola outbreak

    Ebola in the DRC: vaccinating in a conflict zone

    More than two years after the West African Ebola epidemic was declared over, after claiming more than 11,000 lives in…
    Read More…

    12 Dec
  2. Foreign pharma companies in China

    Is China the next great hope for the pharma industry?

    For many industries in the 21st century, it’s hard to escape the feeling that all roads lead to China. The…
    Read More…

    10 Dec

  3. Amazon and PillPack: an unstoppable pharmacy force?

    The US pharmacy industry has been bracing for an Amazon-shaped avalanche for several years now. The online retail giant has…
    Read More…

    27 Sep

  4. The People vs Big Pharma: tackling the industry’s trust issues

    “I sort of view Big Pharma, as an industry, as an octopus with many tentacles, and at the end of…
    Read More…

    20 Aug

  5. Blocking generic competition: will naming and shaming work?

    With the US political spotlight still centred firmly on drug prices, President Donald Trump’s 11 May speech on the topic…
    Read More…

    11 Jul

  6. Shaky foundations: the flaws in animal research reporting

    Animal studies represent one of the fundamental layers of modern clinical research. Preclinical testing of drug candidates on animal models…
    Read More…

    20 Jun

  7. Can the gene and cell therapy revolution scale up?

    As innovative gene and cell therapies continue to make the transition from the laboratory to the clinic, they are bringing…
    Read More…

    28 May

  8. CRISPR: a seismic shift in gene editing

    Given the ubiquity of CRISPR today, it’s hard to believe that the technology was little more than a blip on…
    Read More…

    23 May

  9. Biotech M&A: will the 2018 surge last?

    Over the last 20 years, the pace of mergers and acquisitions (M&A) in the biotech and pharma industries seems to…
    Read More…

    14 May

  10. Boosting biosimilar uptake in the US: what needs to change?

    While the debate over drug prices rages on in the US, there’s one benefit that is often trumpeted by the…
    Read More…

    2 May

Go Top